Join our Community
Support ToI and remove all ads
Learn more

ISRAEL AT WAR - DAY 586

MeMed

MeMed Diagnostics founders Dr. Kfir Oved and Dr. Eran Eden. (Courtesy)
January 10, 2022, 2:21 pm
Medical tech firm MeMed nabs $93m investment to decode body’s immune responses
Company’s BV blood test to distinguish between bacterial and viral infections recently cleared by FDA; investors include Hong Kong’s Horizons Ventures
By Ricky Ben-David
MeMed Diagnostics founders Dr. Kfir Oved and Dr. Eran Eden. (Courtesy)
September 20, 2021, 5:14 pm
Israel’s MeMed gets FDA approval for ‘breakthrough’ infection test
Purpose of test is to tell physicians whether body is waging war on bacteria or virus, and make decisions about whether to treat with antibiotics
By Ricky Ben-David
A technician processing a sample for testing with the MeMed COVID-19 Severity test (courtesy of MeMed)
July 29, 2021, 5:14 pm
Israeli test tells COVID patients their chance of deterioration, on 0-100 scale
People who tested positive give a drop of blood, wait 15 minutes, and discover their coronavirus destiny; if severe, doctors empowered to avert the outcome
By Nathan Jeffay
MeMed's BV test is able to distinguish between bacterial and viral infections (Courtesy)
September 8, 2020, 12:45 pm
MeMed partners with Italy’s DiaSorin to commercialize bacteria vs virus test
Test to be integrated in over 5,000 DiaSorin analyzers, allowing physicians to differentiate between bacterial and viral infections
By Shoshanna Solomon
Illustration of test tubes for blood tests. (photo credit: Kobi Gideon / FLASH90)
From the WebFebruary 7, 2018, 2:42 pm
Automated blood tests startup MeMed wins Department of Defense grant
Calcalist: MeMed has developed an automated blood testing device that is able to diagnose sources of infections in under 15 minutes
MeMed's analyzer is a 'point of need' testing device to find out quickly whether an infection is viral or bacterial (Courtesy)
April 19, 2017, 5:10 pm
MeMed gets $9.2 million contract from US DoD arm
Funds will help develop a bedside device to help distinguish bacterial from viral infections, Israeli firm says
By Shoshanna Solomon
Illustrative photo of pharmaceutical pills. (Abed Rahim Khatib/Flash90)
August 11, 2015, 3:29 pm
Israeli med tech thwarts superbugs’ takeover plans
By determining more precisely what ails patients, MeMed’s technology ensures that they get exactly the meds they need
By David Shamah
Load More
Sign in or Join The Times of Israel Community
Paying ToI Community members are invited to comment on articles
Please use the following structure: example@domain.com
Or Continue with
By joining you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Join The Times of Israel Community
Only ToI Community members can comment below articles
Forgot your password? / Send me a login link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.